Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Phone calls from nurses aim to tame high blood pressure in women

NCT ID NCT03963934

Disease control Sponsor: Mme Edith DAUCHY Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a 6-month program of nurse-led phone calls could help women with uncontrolled high blood pressure take their medication as prescribed. The program included 7 phone calls to address barriers to medication adherence. Only 14 women enrolled before the study was terminated early, so the results are not conclusive.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nurse-led telephone follow-up program
What this could lead to
If successful, this could show that personalized phone support helps women with high blood pressure stick to their medication and lower their blood pressure.
What could go wrong
This was a very small feasibility study that was terminated early, so results are limited. It is not a treatment itself and may not work in larger, more diverse groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

14 people

The number who actually took part.

Started

Oct 2020

Finished

Apr 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 79 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Woman ≥ 18 to 79 years old, * Hypertensive and treated with antihypertensive drug(s) * Unsatisfactory compliance for at least one of her antihypertensive treatment with a score below 80% at the medication adherence scale * Uncontrolled Blood Pressure (BP) : systolic BP equals to or greater than140 and / or diastolic BP equals to or greater than 90 mmHg at inclusion visit * Informed consent signed * Affiliation to a French social security scheme or beneficiary of such a scheme Exclusion Criteria: * Patient with a history of cardio or cerebrovascular disease in the last 6 months (Stroke or Transient Ischemic Attack, myocardial infarction, heart failure) * Patient with kidney failure requiring dialysis * Patient with cognitive pathology: dementia, ... etc. * Patient with type I diabetes * Unreachable patient by phone or foreseeable inability or unwillingness to comply with study follow-up * Patient who does not understand and does not speak French

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arterial hypertension are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

essential hypertension hypertensive disorder Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Arterial hypertension Medication nonadherence

Contacts and locations

Locations

  • CHRU Nancy / Centre Investigation Clinique Plurithématique

    Vandœuvre-lès-Nancy, Meurthe et Moselle, 5450, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.